Tech Company Financing Transactions
Gelesis Funding Round
Cormorant Asset Management participated in a $31.5 million venture round for Gelesis. This VC investment round was announced on 12/18/2015.
Transaction Overview
Company Name
Announced On
12/18/2015
Transaction Type
Venture Equity
Amount
$31,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Gelesis plans to use the proceeds from the financing to enable completion of a six-month U.S. Food and Drug Administration (FDA) pivotal trial of Gelesis100 with topline data expected to be available in the first half of 2017, as well as to support commercial readiness activities in preparation for a potential launch. Funds will also be used for the expected completion of first-in-human studies of its glycemic control product, Gelesis200, with anticipated read-out of a three-month proof-of-concept study expected in the second half of 2016. Gelesis200 was created with the same proprietary technology platform as Gelesis100 and its properties are optimized to improve glycemic control in patients with prediabetes and type 2 diabetes who may or may not require weight loss.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Boylston St. 1600
Boston, MA 02459
USA
Boston, MA 02459
USA
Phone
Website
Email Address
Overview
Gelesis is transforming obesity and diabetes treatments. Learn how our smart pill (Gelesis100) can safely treat obese and diabetic patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yishai Zohar
Chief Marketing Officer
Harry Leider
Chief Operating Officer
David Pass
Chief Scientific Officer
Elaine Chiquette
Chief Scientific Officer
Alessandro Sannino
Executive Vice President
Hassan Heshmati
VP - Regulatory Affairs
Eyal Ron
Browse more venture capital transactions:
Prev: 12/18/2015: Leo venture capital transaction
Next: 12/18/2015: Rivigo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs